newsfilter
← Latest News
Business Wire·

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

Armenia and Nepal are the first of 29 countries to receive BRUKINSA The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and